ALEXANDRA PAGNI: Open Payments
NPI 1740998178 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $706
Food & beverage: $622Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $183 |
| Janssen Biotech, Inc. | 2 | $111 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| ABBVIE INC. | 2 | $37 |
| GENZYME CORPORATION | 1 | $36 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $18 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, ZENPEP, XIFAXAN, EOHILIA, DUPIXENT, IQIRVO.
Industry payments across WI — which companies pay providers there.
